Skip to main content

Table 2 Patient characteristics

From: Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan

 

CapeOX

mFOLFOX6

UFT/LV

Capecitabine

S-1

P

Gender†

 Male/female

32/25

5/5

20/18

10/10

18/11

0.909a

Age‡

65.0 (79-40)

55.5 (73-41)

67.0 (79-40)

60.0 (78-40)

63.0 (80-42)

0.309b

Tumor type

 Colon cancer/rectal cancer†

35/22

9/1

27/11

15/5

17/12

0.372a

Stage†

 I / II / III

0/3/54

0/0/10

0/11/27

0/2/18

4/11/14

<0.001a

Performance status†

 0/1

57/0

10/0

35/3

18/2

29/0

0.0680a

  1. †Number; ‡Median (range)
  2. aχ2 test; bAnalysis of variance